These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35656794)

  • 1. CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability.
    Genin EC; Bannwarth S; Ropert B; Lespinasse F; Mauri-Crouzet A; Augé G; Fragaki K; Cochaud C; Donnarumma E; Lacas-Gervais S; Wai T; Paquis-Flucklinger V
    Brain; 2022 Oct; 145(10):3415-3430. PubMed ID: 35656794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
    Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
    FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
    Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
    Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
    Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
    Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.
    Liu YT; Huang X; Nguyen D; Shammas MK; Wu BP; Dombi E; Springer DA; Poulton J; Sekine S; Narendra DP
    Hum Mol Genet; 2020 Jun; 29(9):1547-1567. PubMed ID: 32338760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Imai Y; Meng H; Shiba-Fukushima K; Hattori N
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD10
    Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
    Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 and PINK1 mediate CHCHD10
    Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
    Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
    Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
    Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
    Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
    Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.
    Genin EC; Plutino M; Bannwarth S; Villa E; Cisneros-Barroso E; Roy M; Ortega-Vila B; Fragaki K; Lespinasse F; Pinero-Martos E; Augé G; Moore D; Burté F; Lacas-Gervais S; Kageyama Y; Itoh K; Yu-Wai-Man P; Sesaki H; Ricci JE; Vives-Bauza C; Paquis-Flucklinger V
    EMBO Mol Med; 2016 Jan; 8(1):58-72. PubMed ID: 26666268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of the Wild-Type and S59L Mutant CHCHD10 Proteins Important in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
    Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
    ACS Chem Neurosci; 2022 Apr; 13(8):1273-1280. PubMed ID: 35349255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal Dementia-Related V57E Mutation Impairs Mitochondrial Function and Alters the Structural Properties of CHCHD10.
    Alici H; Uversky VN; Liu T; Kang DE; Woo JA; Coskuner-Weber O
    ACS Chem Neurosci; 2023 Jun; 14(11):2134-2145. PubMed ID: 37194187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.
    Harjuhaahto S; Rasila TS; Molchanova SM; Woldegebriel R; Kvist J; Konovalova S; Sainio MT; Pennonen J; Torregrosa-Muñumer R; Ibrahim H; Otonkoski T; Taira T; Ylikallio E; Tyynismaa H
    Neurobiol Dis; 2020 Jul; 141():104940. PubMed ID: 32437855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
    Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
    Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
    Ruan Y; Hu J; Che Y; Liu Y; Luo Z; Cheng J; Han Q; He H; Zhou Q
    Cell Death Dis; 2022 Feb; 13(2):156. PubMed ID: 35173147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
    Zhou W; Ma D; Tan EK
    Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.